IP Library Granted Patent US 7,412,978
Granted Patent B1
US 7,412,978 · App. 09/634,038 · Granted Aug 19, 2008

Augmentation and repair of vocal cord tissue defects

Assignee: Isolagen Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,412,978
App. No.
09/634,038
Granted
Aug 19, 2008
Kind
B1
Abstract

A method for corrective surgery in a human subject of a vocal cord defect amenable to rectification by the augmentation of tissue subadjacent to the vocal cord defect, the method comprising: placing an effective amount of autologous in vitro cultured cells into a vocal cord tissue of the subject in a position subadjacent to the vocal cord defect, wherein the vocal cord tissue is selected from the group consisting of a scar, Reinke's space, a muscle of the vocal cord, and the lamina propria, wherein the in vitro cultured cells are obtained by culturing a plurality of viable cells retrieved from the subject, and wherein the cultured cells are suspended in a collagen or modified collagen solution prior to injection of the cultured cells. The in vitro cultured cells can be fibroblasts, e.g., fibroblasts derived from dermis, fascia, connective tissue, or lamina propria.

Claims (10)

1. A method for corrective surgery in a human subject of a vocal cord defect amenable to rectification by the augmentation of tissue subadjacent to the vocal cord defect, the method comprising: placing an effective amount of autologous in vitro cultured cells into a vocal cord tissue of the subject in a position subadjacent to the vocal cord defect,

wherein the vocal cord tissue is selected from the group consisting of a scar, Reinke's space, a muscle of the vocal cord, and the lamina propria,

wherein the in vitro cultured cells are obtained by culturing a plurality of viable cells retrieved from the subject, and

wherein the cultured cells are suspended in a collagen or modified collagen solution prior to injection of the cultured cells.

2. The method of claim 1 wherein the cells are cultured in a collagen or modified collagen matrix.

3. The method of claim 2 wherein the cells and the matrix are placed in the tissue by injection.

4. The method of claim 2 wherein the cells and the matrix are placed in the tissue by engraftment.

5. The method of claim 1 wherein the in vitro cultured cells are fibroblasts.

6. The method of claim 5 wherein the fibroblasts are derived from a tissue selected from the group consisting of dermis, fascia, connective tissue, and lamina propria.

7. The method of claim 1 wherein serum from the subject is used for the in vitro culture of the cells.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL TECHNOLOGIES, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 055641/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: FIBROCELL SCIENCE, INC.
To: CASTLE CREEK BIOSCIENCES, LLC
Reel/Frame 055642/0372 →
CHANGE OF NAME Recorded Aug 24, 2011
From: ISOLAGEN TECHNOLOGIES, INC.
To: FIBROCELL TECHNOLOGIES, INC.
Reel/Frame 026803/0103 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERROR IN ASSIGNEE NAME WHICH IS ISOLAGEN TECHNOLOGIES, INC.; NOW D/B/A FIBROCELL TECHNOLOGIES, INC. PREVIOUSLY RECORDED ON REEL 026709 FRAME 0354. ASSIGNOR(S) HEREBY CONFIRMS THE ENTIRE RIGHT, TITLE AND INTEREST IN THE INVENTIONS WAS TRANSFERRED BY GREGORY S. KELLER TO ASSIGNEE. Recorded Aug 24, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN TECHNOLOGIES, INC.
Reel/Frame 026803/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2011
From: KELLER, GREGORY S.
To: ISOLAGEN, INC.
Reel/Frame 026709/0354 →
CHANGE OF NAME Recorded Jul 15, 2011
From: ISOLAGEN, INC.
To: FIBROCELL SCIENCE, INC.
Reel/Frame 026601/0287 →
Continuity (2)
Division 0900337800 · Jan 6, 1998
Provisional Application 6003796100 · Feb 20, 1997